BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3523516)

  • 1. Current cellular assays for measuring clinical drug metabolizing capacity--impact of new molecular biologic techniques.
    Kouri RE; McLemore T; Jaiswal AK; Nebert DW
    Prog Clin Biol Res; 1986; 214():453-69. PubMed ID: 3523516
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
    Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
    Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial pharmacogenetics.
    Wilke RA; Reif DM; Moore JH
    Nat Rev Drug Discov; 2005 Nov; 4(11):911-8. PubMed ID: 16264434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug metabolism by the cytochrome p-450 enzyme. Variability of polymorphisms and exogenous carriers].
    Kreutzkamp B
    Med Monatsschr Pharm; 2006 Feb; 29(2):48-50. PubMed ID: 16506587
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacogenetics and its importance in the clinical].
    Lares-Asseff I; Trujillo-Jiménez F
    Gac Med Mex; 2001; 137(3):227-36. PubMed ID: 11432091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of knowledge on drug metabolism for the safe use of drugs in humans.
    Oesch F
    Drug Metab Rev; 2009; 41(3):298-300. PubMed ID: 19601716
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.
    Johnson AD; Wang D; Sadee W
    Pharmacol Ther; 2005 Apr; 106(1):19-38. PubMed ID: 15781120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug essentials. The cytochrome P450 microenzyme system and targeted therapies: Minimizing drug interactions.
    Wilkes GM
    Oncology (Williston Park); 2009 Feb; 23(2 Suppl Nurse Ed):33, 52-6. PubMed ID: 19856586
    [No Abstract]   [Full Text] [Related]  

  • 12. Genes and the response to drugs.
    Caraco Y
    N Engl J Med; 2004 Dec; 351(27):2867-9. PubMed ID: 15625340
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic polymorphisms in drug-metabolizing enzymes and drug targets.
    Hiratsuka M; Mizugaki M
    Mol Genet Metab; 2001 Aug; 73(4):298-305. PubMed ID: 11509011
    [No Abstract]   [Full Text] [Related]  

  • 14. [Genetic polymorphism of the hepatic metabolism of drugs].
    Larrey D; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1985; 9(6-7):522-31. PubMed ID: 3926587
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytochromes P450: decision-making tools for personalized therapeutics.
    Murray M; Petrovic N
    Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular map of the human genome as a basis for the study of ethnic differences in reactions to xenobiotics.
    Grzeschik KH
    Prog Clin Biol Res; 1986; 214():479-88. PubMed ID: 3460098
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests.
    Andersson T; Flockhart DA; Goldstein DB; Huang SM; Kroetz DL; Milos PM; Ratain MJ; Thummel K
    Clin Pharmacol Ther; 2005 Dec; 78(6):559-81. PubMed ID: 16338273
    [No Abstract]   [Full Text] [Related]  

  • 18. How the pharmacogenetics of cytochrome P450 enzymes may affect prescribing.
    Roberts RL; Begg EJ; Joyce PR; Kennedy MA
    N Z Med J; 2002 Mar; 115(1150):137-40. PubMed ID: 12013308
    [No Abstract]   [Full Text] [Related]  

  • 19. Population genetic structure of variable drug response.
    Wilson JF; Weale ME; Smith AC; Gratrix F; Fletcher B; Thomas MG; Bradman N; Goldstein DB
    Nat Genet; 2001 Nov; 29(3):265-9. PubMed ID: 11685208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In case of risks and side effects: ask your genes, too].
    Möritz A
    Med Monatsschr Pharm; 2007 May; 30(5):179-83. PubMed ID: 17526394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.